What is Ganga Pharmaceuticals Ltd (539680) share price return in the past 10 years?

Ganga Pharmaceuticals Ltd share price has declined -0.9% annually (CAGR) over the past ten years.

What is the share price of Ganga Pharmaceuticals Ltd (539680)?

Company share prices are keep on changing according to the market conditions. The current trading price of Ganga Pharmaceuticals Ltd (539680) on 12-Feb-2026 16:59:59 at 16:59 is 12.00.

What is the P/E ratio of Ganga Pharmaceuticals?

The latest standalone P/E ratio of Ganga Pharmaceuticals as of 12-Feb-2026 is 89.76.

What is the P/B ratio of Ganga Pharmaceuticals Ltd (539680)?

The latest standalone P/B ratio of Ganga Pharmaceuticals Ltd (539680) as of 12-Feb-2026 is 0.88.

What is the 52-week high and low of Ganga Pharmaceuticals Ltd (539680)?

The 52-week high of Ganga Pharmaceuticals Ltd (539680) is Rs. 14.80 and the 52-week low is Rs. 9.35.

Ganga Pharmaceuticals Ltd (539680) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Ganga Pharmaceuticals Ltd (539680)
Brand: Ganga Pharmaceuticals

Ganga Pharmaceuticals Ltd (539680) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Ganga Pharmaceuticals Ltd (539680)

BSE: 539680 NSE:

Key Metrics

Market Cap

₹7 Cr.

P/E Ratio

89.76

Price to Book (P/B)

0.88

Price to Sales (P/S)

2.69

EV/EBITDA

25.69

Return on Capital Employed (ROCE)

3.22%

Current Price

₹12

Return on Equity (ROE)

1.22%

Return on Assets (ROA)

0.90%

Operating Profit Margin

-4.4%

Net Profit Margin

Gross Profit Margin

5.4%

Book Value per Share

₹13.6

Sales Growth (YoY)

-3.65%

Sales Growth (3 Years)

1.97%

Operating Profit Growth (1 Year)

-300%

Operating Profit Growth (3 Years)

NAN%

Net Profit Growth (1 Year)

60%

52-Week Low / High

₹9 / 15

Net Profit Growth (3 Years)

27.77%

Dividend Yield

0.00%

Promoter Holding

50.91%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Revenue growth of Ganga Pharmaceuticals Ltd?

Ganga Pharmaceuticals Ltd revenue growth is -3.7% for FY-2025 , which is below its 5 year CAGR of -3% , indicating slower growth.

Q.1 Promoter shareholding and pledge status of Ganga Pharmaceuticals Ltd?

Promoters hold 50.91% of the Ganga Pharmaceuticals Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Ganga Pharmaceuticals Ltd vs industry peers?

Ganga Pharmaceuticals Ltd revenue CAGR is -3.04% , compared to the industry median CAGR of 5.54% , indicating slower growth and losing its market share.

Q.1 Which industry/sub-sector does Ganga Pharmaceuticals Ltd belong to?

Ganga Pharmaceuticals Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.

Q.1 Stock return of Ganga Pharmaceuticals Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of -0.9% based on the current price.

DeciZen - make an informed investing decision on Ganga Pharma.

Based on:

Data

M-Cap below 100cr DeciZen not available

Ganga Pharmaceuticals stock performance

Key Ratios

Is Ganga Pharmaceuticals Ltd an attractive stock to invest in?

1. Is Ganga Pharmaceuticals Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Ganga Pharmaceuticals Ltd is a below average quality company.

2. Is Ganga Pharmaceuticals Ltd undervalued or overvalued?

The key valuation ratios of Ganga Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Ganga Pharmaceuticals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Ganga Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	6.9%	6.2%	5.8%	7.3%	7.2%	3.4%	3.4%	3.4%	3.2%	3.2%	-
Value Creation Index ⓘ	-0.5	-0.6	-0.6	-0.5	-0.5	-0.8	-0.8	-0.8	-0.8	-0.8	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	2.6	3	3.1	3.4	3.1	2.4	2.5	2.6	2.7	2.6	3
Sales YoY Gr.	-	14.5%	1.3%	10.2%	-8.3%	-23.1%	5.1%	4%	5.8%	-3.7%	-
Adj EPS ⓘ	0.1	0.2	0.2	0.5	0.5	0.1	0.1	0.1	0.1	-0.1	0.1
YoY Gr.	-	50%	27.8%	100%	0%	-89.1%	80%	11.1%	0%	-210%	-
BVPS (₹) ⓘ	11.2	12	12.2	12.7	13.2	13.2	13.3	13.4	13.3	13.5	13.6
Adj Net Profit ⓘ	0.1	0.1	0.1	0.2	0.2	0	0	0	0.1	-0.1	0
Cash Flow from Ops. ⓘ	-1.1	0.1	0.2	0.1	-0.3	-0.2	-0.2	-0	-1.3	-0.6	-
Debt/CF from Ops. ⓘ	-2.1	46.7	8.6	16.5	-4.8	-9.8	-9.2	-45.8	-1.1	-2.5	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	0%	-3%	2%	-3.7%
Adj EPS ⓘ	-199%	-175.1%	-206.9%	-210%
BVPSⓘ	2.1%	0.4%	0.4%	1.2%
Share Price	-0.9%	9.9%	-4.9%	7.3%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	1.3	1.5	1.9	3.7	3.6	0.4	0.7	0.7	0.8	-0.7	1
Op. Profit Mgn % ⓘ	11.5	10.2	10.5	12.5	12.6	1.4	1.7	0.2	2.1	-4.4	-0.1
Net Profit Mgn % ⓘ	1.9	2.5	3.1	5.6	6.1	0.9	1.5	1.5	1.7	-2	2.9
Debt to Equity ⓘ	0.5	0.4	0.4	0.4	0.3	0.3	0.4	0.3	0.2	0.2	0.2
Working Cap Days ⓘ	689	737	810	746	791	1,041	1,030	1,019	1,011	1,102	237
Cash Conv. Cycle ⓘ	200	244	220	143	167	230	210	198	229	264	146

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 1.00%

Sales growth is good in last 4 quarters at 10.27%

Sales growth has been subdued in last 3 years 1.97%

Net Profit has been subdued in last 3 years -206.92%

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	0.1	-
TTM Sales (₹ Cr.)	2.6	-
BVPS (₹) ⓘ	13.6	-
Reserves (₹ Cr.) ⓘ	2	-
P/BV ⓘ	0.88	-
PE ⓘ	89.76	-

From the Market
52 Week Low / High (₹)	9.35 / 14.80
All Time Low / High (₹)	5.00 / 28.49
Market Cap (₹ Cr.)	7.1
Equity (₹ Cr.)	5.9
Face Value (₹)	10
Industry PE ⓘ	42.1

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Ganga Pharma. - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	2.63	3.01	3.05	3.36	3.08	2.37	2.49	2.59	2.74	2.64
Operating Expenses ⓘ +	2.33	2.70	2.73	2.94	2.69	2.34	2.45	2.58	2.68	2.75
Manufacturing Costs	0.50	0.10	0.14	0.18	0.05	0.02	-0.01	-0.06	-0.01	0.02
Material Costs	0.56	0.80	0.86	0.93	1.23	1.21	1.29	1.30	1.25	1.20
Employee Cost	0.06	0.16	0.18	0.32	0.05	0.03	0.04	0.18	0.18	0.18
Other Costs ⓘ	1.21	1.63	1.55	1.51	1.37	1.07	1.13	1.17	1.25	1.36
Operating Profit ⓘ	0.30	0.31	0.32	0.42	0.39	0.03	0.04	0	0.06	-0.12
Operating Profit Margin (%)	11.5%	10.2%	10.5%	12.5%	12.6%	1.4%	1.7%	0.2%	2.1%	-4.4%
Other Income ⓘ +	0.14	0.16	0.15	0.14	0.17	0.25	0.26	0.30	0.24	0.44
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0.33	0.32	0.28	0.25	0.24	0.20	0.19	0.19	0.18	0.18
Depreciation ⓘ	0.04	0.04	0.06	0.05	0.05	0.05	0.05	0.06	0.05	0.05
Profit Before Tax ⓘ	0.07	0.11	0.13	0.26	0.26	0.04	0.05	0.05	0.06	0.09
Tax ⓘ	0.02	0.03	0.03	0.07	0.07	0.02	0.01	0.01	0.02	0.02
Profit After Tax	0.05	0.07	0.09	0.19	0.19	0.02	0.04	0.04	0.05	0.08
PAT Margin (%)	1.9%	2.5%	3.1%	5.6%	6.1%	0.9%	1.5%	1.5%	1.7%	3.0%
Adjusted EPS (₹)	0.1	0.2	0.2	0.5	0.5	0.1	0.1	0.1	0.1	0.2
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	4.80	4.88	4.97	5.15	5.35	5.37	5.41	5.45	6.43	6.51
Share Capital ⓘ	4.06	4.06	4.06	4.06	4.06	4.06	4.06	4.06	4.84	4.84
Reserves ⓘ	0.74	0.81	0.91	1.09	1.29	1.31	1.35	1.39	1.59	1.67
Debt +	2.19	2.14	2.05	1.87	1.45	1.56	1.81	1.66	1.15	1.25
Long Term Debt	1.32	1.10	0.87	0.66	0.59	0.67	0.89	0.63	0.39	0.23
Short Term Debt	0.87	1.04	1.18	1.21	0.86	0.88	0.92	1.03	0.76	1.01
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0.30	0.53	1.05	0.55	0.56	0.44	0.53	0.58	0.10	0.28
Others Liabilities ⓘ	0.03	0.06	0.16	0.18	0.21	0.29	0.25	0.29	0.96	0.94
Total Liabilities ⓘ	7.33	7.61	8.23	7.76	7.57	7.66	8	7.98	8.65	8.97
Fixed Assets
Net Fixed Assets ⓘ +	0.62	0.62	0.82	0.80	0.76	0.72	0.68	0.64	0.61	0.66
Gross Block	0.98	0.99	1.26	1.29	1.30	1.32	1.33	1.35	1.37	1.47
Accumulated Depreciation	0.36	0.38	0.44	0.49	0.54	0.60	0.65	0.71	0.76	0.80
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investments ⓘ	0.50	0	0	0.09	0.09	0.09	0.09	0.09	0.09	0
Inventories	1.14	1.12	1.14	1.15	1.04	1.13	1.15	1.18	1.24	1.18
Trade Receivables	0.94	1.25	1.58	1.23	1.07	0.82	0.89	0.89	0.92	0.91
Cash Equivalents	0.22	0.55	0.29	0.24	0.01	0.01	0.02	0.03	0.03	0.30
Others Assets ⓘ	3.90	4.06	4.39	4.25	4.60	4.88	5.17	5.16	5.76	5.91
Total Assets ⓘ	7.33	7.61	8.23	7.76	7.57	7.66	8	7.98	8.65	8.97

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	-1.05	0.05	0.24	0.11	-0.31	-0.18	-0.21	-0.04	-1.26	-0.58
PBT ⓘ	0.07	0.11	0.13	0.26	0.26	0.04	0.05	0.05	0.06	0.09
Adjustment ⓘ	0.04	0.19	0.18	0.15	0.11	-0.02	-0.01	-0.06	-0.01	-0.22
Changes in Working Capital ⓘ	-1.15	-0.21	-0.03	-0.23	-0.61	-0.18	-0.23	-0.02	-1.3	-0.44
Tax Paid ⓘ	-0.01	-0.04	-0.04	-0.06	-0.06	-0.01	-0.01	-0.02	-0.02	-0.01
Cash Flow From Investing Activity ⓘ +	-0.83	0.62	-0.14	0.28	0.37	0.28	0.19	0.49	0.13	1.18
Capex	-0.01	0.46	-0.26	-0.03	-0.01	-0.02	-0.01	-0.01	-0.02	-0.10
Net Investments	0	0	0	-0.09	0.21	0.04	-0.05	0.21	-0.09	1.03
Others ⓘ	-0.82	0.16	0.13	0.40	0.16	0.25	0.26	0.30	0.24	0.25
Cash Flow From Financing Activity ⓘ +	1.90	-0.33	-0.36	-0.45	-0.29	-0.10	0.03	-0.44	1.14	-0.33
Net Proceeds from Shares ⓘ	2.11	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0.01	0	0	0	0	0	0	0	-0.24	-0.16
Interest Paid ⓘ	0	-0.31	-0.27	-0.24	-0.22	-0.18	-0.19	-0.19	-0.18	-0.17
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	-0.23	-0.03	-0.09	-0.21	-0.07	0.08	0.22	-0.26	1.56	0
Net Cash Flow ⓘ	0.02	0.33	-0.26	-0.05	-0.22	0	0.01	0.01	0	0.27

Finance Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	1.36	1.57	1.91	3.7	3.59	0.38	0.7	0.72	0.78	1.22
ROCE (%)	6.88	6.15	5.83	7.26	7.18	3.36	3.41	3.38	3.16	3.22
Asset Turnover Ratio	0.43	0.4	0.39	0.42	0.4	0.31	0.32	0.32	0.33	0.3
PAT to CFO Conversion(x)	-21	0.71	2.67	0.58	-1.63	-9	-5.25	-1	-25.2	-7.25
Working Capital Days
Receivable Days	113	133	169	152	136	145	125	126	121	127
Inventory Days	148	137	135	125	130	167	167	165	162	168
Payable Days	240	68	223	314	164	150	137	156	99	58

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Ganga Pharmaceuticals Ltd FAQs

The current trading price of Ganga Pharma. on 12-Feb-2026 16:59 is ₹12.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 11-Feb-2026 the market cap of Ganga Pharma. stood at ₹7.09 Cr

The latest P/E ratio of Ganga Pharma. as of 11-Feb-2026 is 89.76.

The latest P/B ratio of Ganga Pharma. as of 11-Feb-2026 is 0.88.

The 52-week high of Ganga Pharma. is ₹14.80 and the 52-week low is ₹9.35.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Ganga Pharma. is ₹2.64 ( Cr.) .

About Ganga Pharmaceuticals Ltd

No data to display

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Ganga Pharmaceuticals Ltd (539680) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Ganga Pharma. Share Price